Registration - In-house Corporation

Indivior Canada Ltd. / Manon Lafontaine, General Manager

Registration Information

In-house Corporation name: Indivior Canada Ltd.
Previous in-house corporation names
Responsible Officer Name: Manon Lafontaine, General Manager
Responsible Officer Change History
Initial registration start date: 2011-05-24
Registration status: Active
Registration Number: 954995-280204

Associated Communications

Total Number of Communication Reports: 28

Monthly communication reports in the last 6 months: 0

Version 6 of 19 (2013-05-17 to 2013-06-12)

Registration versions:

Version 6 of 19 (2013-05-17 to 2013-06-12)

Lobbying Information

Subject Matters

Aboriginal Affairs
Budget
Consumer Issues
Health
Industry
Intellectual Property
International Trade
Research and Development
Science and Technology
Taxation and Finance

Subject matters added through a monthly communication report

Defence

Subject Matter Details

Legislative Proposal, Bill or Resolution

The upcoming Food and Drugs Act Modernization legislative proposal (Act and Regulations) as it relates to improving the efficiency of the drug review and approval process.

Legislative Proposal, Bill or Resolution, Regulation

Food and Drugs Act & Regulations with respect to Drug Export Restrictions and international trade.
The Food and Drugs Act and Regulations with respect to their impact on addiction treatments.

Policies or Program

A national pharmacare strategy with respect to the need for full coverage/reimbursement of opioid dependence treatments and addiction treatments.
Common Drug Review with respect to reimbursement decisions and the approval process.
Coverage of opioid dependence treatments and addiction treatments with respect to Canadian Forces returning to Canada from active duty overseas.
Government of Canada Drug Plans, with respect to the reimbursement of therapeutic products relevant beneficiaries.
Non-Insured Health Benefits under Health Canada with regards to reimbursement criteria of opioid dependence & addiction treatments for First Nations, Inuit and Metis in Canada.
The National Anti-Drug Strategy with respect to public relations and awareness programs relating to addiction and opioid dependence.
The federal Science & Technology Strategy and/or any federal Government policy or program initiatives to support Research and Development in Canada, and advocate for the development of a pharmaceutical sectoral strategy in support of more research & development in Canada
The national prescription drug abuse strategy, "First Do No Harm: Responding to Canada's Prescription Drug Crisis" with respect to risk mitigation strategies for the pharmaceutical industry to ensure high quality patient care, reform of the drug approval process in Canada and the launch of a national prescription drug monitoring and surveillance system.

Regulation

Patented Medicine Prices Review Board (PMPRB) Regulations as it relates to reporting requirements and pricing guidelines.
Patented Medicines Regulations (Notice of Compliance) with respect to regulating intellectual property for therapeutic products

Communication Techniques

Written communication
Oral communication
Participation in Industry Associations and delegations

Government Institutions

Aboriginal Affairs and Northern Development Canada
Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
House of Commons
Industry Canada
Justice Canada (JC)
National Defence (DND)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Safety Canada (PS)
Royal Canadian Mounted Police (RCMP)
Senate of Canada
Veterans Affairs Canada (VAC)

In-house Corporation Details

Description of activities

Reckitt Benckiser Pharmaceuticals Inc. is committed to optimizing standards of patient care and minimizing risks of diversion and abuse through programs of education and intervention that we believe represent a benchmark for the pharmaceutical industry in the therapeutic area of addiction treatment.

Responsible officer name and position during the period of this registration

Richard Simkin, President & CEO (North America)

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
10710 Midlothian Turnpike
Richmond, VA 23235
United States of America

Telephone number: 804-379-1090
Fax number: 804-379-1090

Parent Company Information

Reckitt Benckiser Group / Groupe Reckitt Benckiser
- Suite 103
  105 Bath Road
  Slough, Berkshire SL13UH
  United Kingdom

Subsidiary Beneficiary Information

RB Pharmaceuticals Ltd. / RB Pharmaceuticals Ltd
- 103 - 105 Bath Road
  Slough, Berkshire SL13UH
  United Kingdom

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Rolley Johnson, Vice President, Treatment & Health Policy | No public offices held
Richard Simkin, President & CEO (North America) | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Cameron Bishop, Manager, Treatment, Health Policy & Government Affairs | Public offices held

Indivior Canada Ltd./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Indivior Canada Ltd./	2024-04-01	current
Indivior Canada Ltd./	2023-04-09	2024-04-01
Indivior Canada Ltd./Indivior (Canada) Ltd.	2015-07-01	2017-07-16
RBP Canada Ltd., a subsidiary of Indivior PLC	2015-01-01	2015-07-01
Reckitt Benckiser Pharmaceuticals Inc/Reckitt Benckiser Pharmaceuticals Inc.	2011-05-24	2015-01-01

The following names have been used before July 2, 2008

Reckitt Benckiser Pharmaceuticals Inc/Reckitt Benckiser Pharmaceuticals Inc.

Indivior Canada Ltd.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Manon Lafontaine	2023-04-09	Current
Richard Simkin	2012-01-01	2017-07-16
Gary Phillips	2011-05-24	2012-01-01

Manon Lafontaine, General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-28 of 28

Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Connor MacDonald, Policy Advisor | Office of the Leader of the Opposition | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-05-23
Posted date: 2023-07-14
Communication number: 280204-572562 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terence Young, Member of Parliament | House of Commons
- Hedy Fry, Member of Parliament | House of Commons
- Peter Stoffer, Member of Parliament | House of Commons
- Ben Lobb, Chair, Standing Committee on Health & Member of Parliament | House of Commons
- Carol Hughes, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-11-19
Posted date: 2014-12-15
Communication number: 280204-341721 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Andrews, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-10-27
Posted date: 2014-11-14
Communication number: 280204-338632 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Weston, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-05-26
Posted date: 2014-06-15
Communication number: 280204-325829 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terence Young, Member of Parliament for Oakville | House of Commons
Subject Matter of the communication: Consumer Issues, Health
Communication date: 2014-03-27
Posted date: 2014-04-15
Communication number: 280204-320949 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ben Lobb, Chair, Standing Committee on Health | House of Commons
Subject Matter of the communication: Consumer Issues, Health
Communication date: 2014-03-25
Posted date: 2014-04-15
Communication number: 280204-320212 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rosa Kouri, Policy Advisor/Parliamentary Affairs | Office of the Leader of the Opposition | House of Commons
Subject Matter of the communication: Consumer Issues, Health
Communication date: 2014-03-11
Posted date: 2014-03-25
Communication number: 280204-320211 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Director | Pharmaceutical Sector Directorate | Industry Canada
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2014-01-09
Posted date: 2014-02-15
Communication number: 280204-313265 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Bouvier, Policy Advisor | Office of the Leader of the Liberal Party | House of Commons
- Rick Theis, Policy Advisor | Office of the Leader of the Liberal Party | House of Commons
Subject Matter of the communication: Health, Defence, Aboriginal Affairs
Communication date: 2013-06-12
Posted date: 2013-07-15
Communication number: 280204-276880 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christine Moore, Member of Parliament (Abitibi-Témiscamingue) | House of Commons
Subject Matter of the communication: Health, Defence, Aboriginal Affairs
Communication date: 2013-06-12
Posted date: 2013-07-15
Communication number: 280204-276879 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bruce Hyer, Member of Parliament (Thunder Bay-Superior North) | House of Commons
- Andrew Blair, Legislative Assistant | Office of Bruce Hyer, M.P. | House of Commons
Subject Matter of the communication: Health, Defence, Aboriginal Affairs
Communication date: 2013-06-12
Posted date: 2013-07-15
Communication number: 280204-276878 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Chief of Staff | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2013-06-06
Posted date: 2013-07-15
Communication number: 280204-276016 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hedy Fry, Member of Parliament & Liberal Party of Canada Health Critic | House of Commons | House of Commons
- Leona Aglukkaq, Minister of Health | Health Canada (HC)
- Sandy Lee, Ministerial Assistant | Office of the Minister of Health | Health Canada (HC)
- Ted Laking, Policy Advisor | Office of the Minister of Health | Health Canada (HC)
- Peter Stoffer, Member of Parliament & NDP Critic for Veterans Affairs | House of Commons | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2013-04-29
Posted date: 2013-05-09
Communication number: 280204-272529 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John McKay, Member of Parliament | House of Commons
- Matt Luloff, Legislative Assistant | Office of John McKay, M.P. | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-11-20
Posted date: 2012-12-15
Communication number: 280204-250569 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandra Buckler, Chief of Staff | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2012-08-13
Posted date: 2012-09-15
Communication number: 280204-233449 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Peter Stoffer, Member of Parliament & Official Opposition Critic (Veteran Affairs) | House of Commons
- Sean Casey, Member of Parliament & Veteran Affairs Critic (Liberal Party) | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-06-06
Posted date: 2012-07-15
Communication number: 280204-225691 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelly Block, Member of Parliament | House of Commons
- Josh Boyes, Member's Assistant | Office of Kelly Block, M.P. | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-06-05
Posted date: 2012-07-15
Communication number: 280204-225508 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Carolyn Bennett, Member of Parliament & Aboriginal Affairs Critic (Liberal Party) | House of Commons
- Dr. Hedy Fry, Member of Parliament & Health Critic (Liberal Party) | House of Commons
- Vincent Haraldsen, Senior Policy Advisor | Office of Dr. Carolyn Bennett, P.C., M.P. | House of Commons
- Ryan Cotter, Legislative Assistant | Office of Dr. Hedy Fry, P.C., M.P. | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2012-06-04
Posted date: 2012-07-15
Communication number: 280204-225387 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hedy Fry, Member of Parliament for Vancouver Centre & Liberal Party Critic for Health | House of Commons
- Ryan Cotter, Legislative Assistant | Office of Dr. Hedy Fry, M.P. for Vancouver Centre | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-04-30
Posted date: 2012-05-15
Communication number: 280204-220767 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Weston, Member of Parliament for West Vancouver-Sunshine Coast-Sea to Sky Country | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2012-04-02
Posted date: 2012-05-15
Communication number: 280204-214727 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jane Cordy, Senator | Senate Committee on Social Affairs, Science and Technology | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2012-03-27
Posted date: 2012-03-29
Communication number: 280204-214067 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Joy Smith, Member of Parliament, Kildonan-St.Paul | Chair, Standing Committee on Health | House of Commons
- Cory Anderson, Parliamentary Assistant | Office of Joy Smith, M.P. | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-03-27
Posted date: 2012-03-29
Communication number: 280204-213847 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Wladyslaw Lizon, Member of Parliament for Mississauga East-Cooksville | Member, Standing Committee on Health | House of Commons
- Crystal Kapteyn, Legislative Assistant | Office of Wladyslaw Lizon, M.P. | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-03-26
Posted date: 2012-03-29
Communication number: 280204-213667 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kenneth Ogilvie, Senator, Chair, Senate Committee on Social Affairs, Science & Technology | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2012-03-13
Posted date: 2012-03-29
Communication number: 280204-211869 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carolyn Bennett, Liberal Critic (Aboriginal Affairs) | Member of Parliament | House of Commons
- Hedy Fry, Liberal Critic (Health) | Member of Parliament | House of Commons
- Daniel Rubinstein, Legislative Assistant | Office of the Honourable Dr. Carolyn Bennett, P.C., M.P. | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2012-02-28
Posted date: 2012-03-29
Communication number: 280204-214087 (amended from 280204-210627) View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Cathy Sabiston, Director General | Director General, Controlled Substances & Tobacco Secretariat | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2011-06-07
Posted date: 2011-07-15
Communication number: 280204-175609 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Supriya Sharma, Director General | Therapeutic Products Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2011-06-07
Posted date: 2011-07-15
Communication number: 280204-175608 View associated registration
Indivior Canada Ltd.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Carrie, M.P & Parliamentary Secretary to the Minister of Health | House of Commons
Subject Matter of the communication: Health
Communication date: 2011-06-07
Posted date: 2011-07-15
Communication number: 280204-175605 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Press Secretary Health Canada, Office of the Minister of Public Health	January 2005 to February 2006	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Indivior Canada Ltd. / Manon Lafontaine, General Manager

Registration Information

Associated Communications

Version 6 of 19 (2013-05-17 to 2013-06-12)

Version 6 of 19 (2013-05-17 to 2013-06-12)

Subject Matters

Subject matters added through a monthly communication report

Subject Matter Details

Legislative Proposal, Bill or Resolution

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties